Previous Close | 1.9500 |
Open | 1.9700 |
Bid | 1.8400 x 800 |
Ask | 1.9400 x 800 |
Day's Range | 1.8600 - 1.9800 |
52 Week Range | 1.3300 - 10.2400 |
Volume | |
Avg. Volume | 829,564 |
Market Cap | 61.063M |
Beta (5Y Monthly) | 0.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEW YORK (AP) — Actinium Pharmaceuticals Inc. ATNM) on Monday reported a loss of $11.4 million in its second quarter. On a per-share basis, the New York-based company said it had a loss of 38 cents.
Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.
Here is how Affimed N.V. (AFMD) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.